Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease: Two-Year Follow-up in the PREDIMED-Plus Study

Autor: Carlos Gómez-Martínez, Nancy Babio, Jordi Júlvez, Nerea Becerra-Tomás, Miguel Á. Martínez-González, Dolores Corella, Olga Castañer, Dora Romaguera, Jesús Vioque, Ángel M. Alonso-Gómez, Julia Wärnberg, José A. Martínez, Luís Serra-Majem, Ramón Estruch, Francisco J. Tinahones, José Lapetra, Xavier Pintó, Josep A. Tur, José López-Miranda, Aurora Bueno-Cavanillas, José J. Gaforio, Pilar Matía-Martín, Lidia Daimiel, Vicente Martín-Sánchez, Josep Vidal, Clotilde Vázquez, Emilio Ros, Søren Dalsgaard, Carmen Sayón-Orea, José V. Sorlí, Rafael de la Torre, Itziar Abete, Lucas Tojal-Sierra, Francisco J. Barón-López, Noelia Fernández-Brufal, Jadwiga Konieczna, Antonio García-Ríos, Emilio Sacanella, M. Rosa Bernal-López, José M. Santos-Lozano, Cristina Razquin, Andrea Alvarez-Sala, Albert Goday, M. Angeles Zulet, Jessica Vaquero-Luna, Javier Diez-Espino, Aida Cuenca-Royo, Fernando Fernández-Aranda, Mònica Bulló, Jordi Salas-Salvadó
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Male
medicine.medical_specialty
Cognition disorders
Endocrinology
Diabetes and Metabolism

030209 endocrinology & metabolism
Glycemic Control
prediabetes
Type 2 diabetes
diabetes duration
Trastorns de la cognició
Diseases of the endocrine glands. Clinical endocrinology
03 medical and health sciences
chemistry.chemical_compound
Cognition
Endocrinology
0302 clinical medicine
Insulin resistance
insulin resistance
Diabetes mellitus
Internal medicine
medicine
Humans
Hypoglycemic Agents
Cognitive Dysfunction
Prospective Studies
Prediabetes
glycated (glycosylated) hemoglobin
Cognitive decline
cognitive function
Aged
Glucose Metabolism Disorders
Original Research
Glycemic
Diabetis
business.industry
Malalties cardiovasculars
Diabetes
Middle Aged
RC648-665
medicine.disease
3. Good health
Cardiovascular diseases
chemistry
Female
type 2 diabetes
Glycated hemoglobin
Metabolic syndrome
business
030217 neurology & neurosurgery
Zdroj: Dipòsit Digital de la UB
Universidad de Barcelona
Frontiers in Endocrinology
Gómez-Martínez, C, Babio, N, Júlvez, J, Becerra-Tomás, N, Martínez-González, M Á, Corella, D, Castañer, O, Romaguera, D, Vioque, J, Alonso-Gómez, Á M, Wärnberg, J, Martínez, J A, Serra-Majem, L, Estruch, R, Tinahones, F J, Lapetra, J, Pintó, X, Tur, J A, López-Miranda, J, Bueno-Cavanillas, A, Gaforio, J J, Matía-Martín, P, Daimiel, L, Martín-Sánchez, V, Vidal, J, Vázquez, C, Ros, E, Dalsgaard, S, Sayón-Orea, C, Sorlí, J V, de la Torre, R, Abete, I, Tojal-Sierra, L, Barón-López, F J, Fernández-Brufal, N, Konieczna, J, García-Ríos, A, Sacanella, E, Bernal-López, M R, Santos-Lozano, J M, Razquin, C, Alvarez-Sala, A, Goday, A, Zulet, M A, Vaquero-Luna, J, Diez-Espino, J, Cuenca-Royo, A, Fernández-Aranda, F, Bulló, M & Salas-Salvadó, J 2021, ' Glycemic Dysregulations Are Associated With Worsening Cognitive Function in Older Participants at High Risk of Cardiovascular Disease : Two-Year Follow-up in the PREDIMED-Plus Study ', Frontiers in Endocrinology, vol. 12, 754347 . https://doi.org/10.3389/fendo.2021.754347
Frontiers in Endocrinology, Vol 12 (2021)
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Popis: The authors wish to thank the PREDIMED-Plus participants and staff for their engagement, as well as to the primary care centers involved in the study. We also thank the Cerca Programme of the Generalitat de Catalunya, and the CIBEROBN, CIBERESP and CIBERDEM initiatives of Instituto de Salud Carlos III in Spain, and the collaborators in the PRIME consortium for helpful input. The first version of the present article has been published in the public repository Research Square as a preprint publication of our work (44). We particularly thank Stephanie Nishi for her assistance with manuscript language revision.
Introduction: Type 2 diabetes has been linked to greater cognitive decline, but other glycemic parameters such as prediabetes, diabetes control and treatment, and HOMA-IR and HbA1c diabetes-related biomarkers have shown inconsistent results. Furthermore, there is limited research assessing these relationships in short-term studies. Thus, we aimed to examine 2-year associations between baseline diabetes/glycemic status and changes in cognitive function in older participants at high risk of cardiovascular disease. Methods: We conducted a 2-year prospective cohort study (n=6,874) within the framework of the PREDIMED-Plus study. The participants (with overweight/obesity and metabolic syndrome; mean age 64.9 years; 48.5% women) completed a battery of 8 cognitive tests, and a global cognitive function Z-score (GCF) was estimated. At baseline, participants were categorized by diabetes status (no-diabetes, prediabetes, and
CIBERESP
Generalitat de Catalunya
Instituto de Salud Carlos III
Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
Databáze: OpenAIRE